Design Therapeutics reported total assets of $215.13M and total liabilities of $13.27M for the quarter ended Jun 2026, down 3.5% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 357.66M | 298.57M | 287.31M | 119.65M | 42.52M | 26.50M | 28.81M | 27.20M | 27.94M | 21.20M | 29.40M | 45.70M | 30.33M | 22.56M | 13.67M | 19.70M | 15.09M | 16.86M | 12.77M | 12.91M | ||||||
| Short-term InvestmentsInvestments (Current) | 36.06M | 85.50M | 83.91M | 239.72M | 301.72M | 303.89M | 286.58M | 275.89M | 263.00M | 260.60M | 241.29M | 215.32M | 223.75M | 222.91M | 216.01M | 196.57M | 190.88M | 202.99M | 210.05M | 194.49M | ||||||
| Cash & Current Investments | 393.72M | 384.06M | 371.22M | 359.38M | 344.23M | 330.39M | 315.39M | 303.09M | 290.94M | 281.80M | 270.69M | 261.02M | 254.07M | 245.48M | 229.67M | 216.28M | 205.97M | 219.84M | 222.82M | 207.40M | ||||||
| Prepaid Assets | 1.57M | 1.37M | 2.65M | 2.35M | 4.25M | 4.73M | 3.55M | 2.96M | 3.60M | 2.79M | 3.20M | 3.83M | 3.17M | 2.56M | 3.97M | 3.52M | 3.06M | 3.94M | 4.23M | 4.62M | ||||||
| Current Assets | 395.29M | 385.44M | 373.87M | 361.72M | 348.49M | 335.12M | 318.94M | 306.05M | 294.54M | 284.58M | 273.89M | 264.84M | 257.24M | 248.04M | 233.64M | 219.79M | 209.03M | 223.78M | 227.05M | 212.01M | ||||||
| Non-Current Assets | ||||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 1.32M | 1.51M | 1.45M | 1.80M | 1.84M | 1.95M | 1.91M | 1.86M | 1.78M | 1.69M | 1.72M | 1.73M | 1.56M | 1.41M | 1.38M | 1.26M | 1.10M | 0.98M | 0.82M | 0.69M | ||||||
| Other Non-Current Assets | 0.47M | 0.47M | 0.46M | 0.45M | 0.44M | 0.44M | 0.43M | 0.43M | 0.43M | 0.43M | 0.43M | 0.43M | ||||||||||||||
| Non-Current Assets | 5.06M | 5.12M | 4.93M | 6.21M | 6.08M | 6.02M | 5.80M | 5.58M | 5.33M | 5.06M | 4.91M | 4.74M | 4.39M | 4.05M | 3.83M | 3.09M | 2.74M | 2.42M | 3.39M | 3.12M | ||||||
| Assets | 400.35M | 390.56M | 378.80M | 367.93M | 354.57M | 341.14M | 324.74M | 311.63M | 299.87M | 289.64M | 278.79M | 269.58M | 261.63M | 252.09M | 237.47M | 222.89M | 211.77M | 226.20M | 230.44M | 215.13M | ||||||
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payables | 2.22M | 1.62M | 1.90M | 2.07M | 2.62M | 3.02M | 2.74M | 1.92M | 2.21M | 1.94M | 1.37M | 1.30M | 1.47M | 2.19M | 3.18M | 1.01M | 1.91M | 2.31M | 2.28M | 3.14M | ||||||
| Payables | 2.22M | 1.62M | 1.90M | 2.07M | 2.62M | 3.02M | 2.74M | 1.92M | 2.21M | 1.94M | 1.37M | 1.30M | 1.47M | 2.19M | 3.18M | 1.01M | 1.91M | 2.31M | 2.28M | 3.14M | ||||||
| Accumulated Expenses | 3.29M | 3.66M | 3.58M | 5.32M | 7.79M | 7.75M | 6.30M | 10.21M | 10.18M | 7.68M | 5.72M | 5.10M | 5.96M | 6.28M | 5.06M | 7.73M | 9.26M | 10.74M | 7.91M | 8.10M | ||||||
| Other Accumulated Expenses | ||||||||||||||||||||||||||
| Total Current Liabilities | 5.50M | 5.28M | 5.48M | 7.39M | 10.41M | 10.78M | 9.05M | 12.13M | 12.39M | 9.62M | 7.09M | 6.39M | 7.43M | 8.46M | 8.24M | 8.75M | 11.17M | 13.05M | 10.19M | 11.24M | ||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||
| Operating Leases | 3.27M | 3.14M | 3.01M | 3.38M | 3.22M | 3.05M | 2.88M | 2.70M | 2.52M | 2.33M | 2.14M | 1.95M | 1.74M | 1.53M | 1.32M | 1.10M | 0.88M | 0.65M | 2.20M | 2.03M | ||||||
| Other Non-Current Liabilities | 0.01M | |||||||||||||||||||||||||
| Total Non-Current Liabilities | 8.78M | |||||||||||||||||||||||||
| Total Liabilities | 8.79M | 8.43M | 8.49M | 10.77M | 13.63M | 13.83M | 11.93M | 14.84M | 14.91M | 11.96M | 9.24M | 8.34M | 9.18M | 10.00M | 9.56M | 9.85M | 12.05M | 13.70M | 12.39M | 13.27M | ||||||
| Shareholder's Equity | ||||||||||||||||||||||||||
| Common Equity | 391.56M | 382.13M | 370.31M | 357.16M | 340.94M | 327.31M | 312.82M | 296.80M | 284.96M | 277.69M | 269.56M | 261.24M | 252.45M | 242.10M | 227.92M | 213.04M | 199.72M | 212.50M | 218.05M | 201.86M | ||||||
| Liabilities and Shareholders Equity | 400.35M | 390.56M | 378.80M | 367.93M | 354.57M | 341.14M | 324.74M | 311.63M | 299.87M | 289.64M | 278.79M | 269.58M | 261.63M | 252.09M | 237.47M | 222.89M | 211.77M | 226.20M | 230.44M | 215.13M | ||||||
| Retained Earnings | -36.39M | -47.46M | -60.72M | -75.72M | -93.42M | -110.76M | -130.10M | -150.00M | -165.80M | -177.63M | -188.73M | -200.52M | -213.60M | -227.21M | -244.93M | -264.01M | -281.01M | -297.01M | -314.64M | -334.81M | ||||||
| Treasury Shares |